Amy R. Dunn

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

Kelly M. Lohr, Alison I. Bernstein, Kristen A. Stout et al. · Proceedings of the National Academy of Sciences · 2014 · 235 citations · Full text

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Amy R. Dunn, Kristen A. Stout, Minagi Ozawa et al. · Proceedings of the National Academy of Sciences · 2017 · 151 citations · Full text

Synaptic Transmission, Neurotransmitter, Neurochemical Biomarkers +22

Increased Vesicular Monoamine Transporter 2 (VMAT2;<i>Slc18a2</i>) Protects against Methamphetamine Toxicity

Kelly M. Lohr, Kristen A. Stout, Amy R. Dunn et al. · ACS Chemical Neuroscience · 2015 · 69 citations · Full text

Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals

Kelly M. Lohr, Merry Chen, Carlie Hoffman et al. · Toxicological Sciences · 2016 · 51 citations · Full text

Mouse Striatal Terminals, Excess Dopamine, Molecular Neuroscience +15

Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo

Laura M. Vecchio, Patricia Sullivan, Amy R. Dunn et al. · Journal of Neurochemistry · 2021 · 46 citations · Full text